Armata Pharmaceuticals Inc.
ARMP | AMEX
$4.26
+$0.08 (+1.91%)
At close: Sep 21, 2026, 4:00 PM ET
$4.15
-$0.11 (-2.58%)
Pre-market:
Sep 22, 2026, 5:22 AM ET
Market Data
Market Cap $153.45M
Enterprise Value $240.46M
Beta 1.35
Average Volume 128.92K
Shares Outstanding (Diluted) 62.04M
Shares Change YoY 71.42%
Institutional Ownership 10.75%
Exchange AMEX
ISIN US04216R1023
Price Performance
Price Change 1M -14.3%
Price Change 3M -39.2%
Price Change 6M -50.5%
Price Change YTD -35.1%
Price Change 1Y 41.1%
Price Change 3Y 59.0%
Price Change 5Y 17.2%
1M CAGR (ann.) -11.1%
1Y CAGR (ann.) 41.2%
5Y CAGR (ann.) 1.3%
All-Time CAGR -33.5%
Valuation
PE Ratio -0.56
Forward PE N/A
PEG Ratio 0.01
Forward PEG 0.04
PS Ratio 47.40
Forward PS 56.90
PB Ratio -0.68
P/FCF Ratio -6.06
P/Adj. FCF Ratio -4.96
P/OCF Ratio -6.17
EV/Sales 72.89
EV/EBIT -1.41
EV/EBITDA -1.42
EV/FCF -9.32
Earnings Yield -178.2%
FCF Yield -16.5%
Adj. FCF Yield -20.1%
Financial Health
Net Debt $84.07M
Total Debt $108.03M
Cash & Short-Term Investments $23.95M
Total Assets $89.95M
Current Ratio 0.11
Quick Ratio 0.11
Debt / Equity Ratio -1.36
Debt / EBITDA -0.64
Debt / FCF -4.19
OCF / Debt -0.24
Interest Coverage -1.90
Altman Z-Score -17.37
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 68.2%
Operating Profit Margin -1233.6%
EBITDA Margin -5121.8%
Net Profit Margin -5825.3%
FCF Margin -781.9%
Adj. FCF Margin -955.3%
SBC / Revenue 173.4%
SBC Impact (per share) -22.2%
Returns
Return on Assets -213.7%
Return on Equity 89.7%
Return on Invested Capital -47.4%
Return on Capital Employed 25.4%
Return on Tangible Assets -252.2%
Historical Growth (CAGR)
Revenue CAGR 3Y -7.5%
Revenue CAGR 5Y 1.7%
Revenue CAGR 10Y 21.3%
EPS CAGR 3Y -73.6%
EPS CAGR 5Y -50.4%
EPS CAGR 10Y 47.3%
FCF CAGR 3Y 29.3%
FCF CAGR 5Y 6.7%
FCF CAGR 10Y -14.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y 29.2%
Revenue Growth Next 3Y 79.3%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.57
EPS Growth Est (next Q) -23.0%
Revenue Est (next Q) $450K
Revenue Growth Est (next Q) -61.2%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $15
Price Target Upside 252.1%
Cash Flow
Operating Cash Flow $-25.42M
Free Cash Flow $-25.79M
Adj. Free Cash Flow $-31.51M
FCF Per Share -$0.70
OCF Per Share -$0.69
OCF/S Ratio -770.5%
Income Statement
Revenue $3.3M
Gross Profit $2.84M
Operating Income $-40.7M
EBITDA $-169.56M
Net Income $-192.18M
EPS (Diluted) -$7.59
Revenue / Employee $54.08K
Profit / Employee $-3.15M
Employees 61
Add to Watchlist
Select watchlists to add or remove ARMP